Results Efficacy
* median SLEDAI dropped from 12 to 4 at week 12
* SRI-4 of 100% at week 12 (not other timepoints)
* at week 36 (last visit) SRI-4 still 70%, median SLEDAI still 4, 3 flares
Safety:
* 5/10 patients had IgG < 5g/l triggering IVIG repletion
* no severe AEs/infections occured
4/
